[Link]
http://dx.doi.org/10.1016/j.neuroscience.2015.02.024
[Link]
mailto:helene.walter@uk-koeln.de
[Link]
http://dx.doi.org/10.1016/j.neuroscience.2015.02.024
IN VIVO ANALYSIS OF NEUROINFLAMMATION IN THE LATE
CHRONIC PHASE AFTER EXPERIMENTAL STROKE
H. L. WALTER,a,b* M. WALBERER,a M. A. RUEGER,a,b
H. BACKES,b D. WIEDERMANN,b M. HOEHN,b,c
B. NEUMAIER,b R. GRAF,b G. R. FINKa,d AND
M. SCHROETERa,b
aDepartment of Neurology, University Hospital Cologne,
Kerpener Straße 62, 50937 Cologne, Germany
bMax-Planck-Institute for Neurological Research, Gleueler Straße
50, 50931 Cologne, Germany
cDepartment of Radiology, Leiden University Medical
Center, Einthovenweg 20, 2333 ZC Leiden, Netherlands
dInstitute of Neuroscience and Medicine (INM-3), Cognitive
Neuroscience, Research Centre Ju ¨lich, 52425 Ju ¨lich, Germany
Abstract—Background and purpose: In vivo imaging of
inflammatory processes is a valuable tool in stroke
research. We here investigated the combination of two
imaging modalities in the chronic phase after cerebral ischemia
: magnetic resonance imaging (MRI) using intravenously
applied ultra small supraparamagnetic iron oxide particles
(USPIO), and positron emission tomography (PET) with the
tracer [11C]PK11195. Methods: Rats were subjected to permanent
middle cerebral artery occlusion (pMCAO) by the
macrosphere model and monitored by MRI and PET for 28
or 56 days, followed by immunohistochemical endpoint analysis.
To our knowledge, this is the first study providing
USPIO-MRI data in the chronic phase up to 8 weeks after
stroke. Results: Phagocytes with internalized USPIOs
induced MRI-T2⁄ signal alterations in the brain. Combined
analysis with [11C]PK11195-PET allowed quantification of
phagocytic activity and other neuroinflammatory processes.
From 4 weeks after induction of ischemia, inflammation was
dominated by phagocytes. Immunohistochemistry revealed
colocalization of Iba1+ microglia with [11C]PK11195 and
ED1/CD68 with USPIOs. USPIO-related iron was distinguished
from alternatively deposited iron by assessing
MRI before and after USPIO application. Tissue affected by
non-phagocytic inflammation during the first week mostly
remained in a viably vital but remodeled state after 4 or
8 weeks, while phagocytic activity was associated with severe
injury and necrosis accordingly. Conclusions: We conclude
that the combined approach of USPIO-MRI and
[11C]PK11195-PET allows to observe post-stroke inflammatory
processes in the living animal in an intraindividual
and longitudinal fashion, predicting long-term tissue fate.
The non-invasive imaging methods do not affect the
immune system and have been applied to human subjects
before. Translation into clinical applications is therefore feasible.  2015 IBRO. Published by Elsevier Ltd. All rights
reserved.
Key words: chronic post-stroke phase, in vivo imaging, PET,
MRI, phagocytic activity, regional tissue fate.
INTRODUCTION
Cerebral ischemia is accompanied by various cellular and
molecular processes, which contribute to restoration of
brain function after stroke (Wieloch and Nikolich, 2006;
Murphy and Corbett, 2009). Especially inflammation
impacts on neuroplasticity and long-term recovery (del
Zoppo, 2010; Morrison and Filosa, 2013; Ruscher et al.,
2013). In vivo visualization of inflammatory reactions
may facilitate translation of novel therapies into clinical
studies (Fumagalli et al., 2013; Heiss, 2014;
Quattromani et al., 2014). Among others, magnetic resonance
imaging (MRI) using ultra small supraparamagnetic
iron oxide particles (USPIO) (Deddens et al., 2012;
Marinescu et al., 2013) and positron emission tomography
(PET) with the radiotracer [11C]PK11195 (Schroeter
et al., 2009; Jacobs et al., 2012) represent attractive
approaches.
The lipophilic tracer [11C]PK11195 binds to the 18-kDa
translocator protein (TSPO), a cholesterol-transporter
found on the membrane of mitochondria (Papadopoulos
et al., 2006). After brain injury, its expression on microglia,
astrocytes and macrophages increases, representing a
target for imaging (Stephenson et al., 1995; Chen and
Guilarte, 2008). Unfortunately the method is limited due
to short half-life of 11C and low signal-to-noise ratio
(Jucaite et al., 2012; Dickens et al., 2014). Moreover
radiosynthesis of [11C]PK11195 is very time consuming
and expensive.
In MRI, intravenously applied USPIOs lead to
hypointense T2⁄-signal changes in the lesioned central
nervous system (CNS) by invasion of USPIO-loaded
macrophages (Nighoghossian et al., 2007; Desestret
et al., 2013). This was shown to occur independently of
a potentially associated blood–brain barrier breakdown
(Stoll and Bendszus, 2010; Yang et al., 2013).
Translational approaches demonstrated USPIO+ phagocytes
also in the human CNS after stroke (Saleh et al.,
http://dx.doi.org/10.1016/j.neuroscience.2015.02.024
0306-4522/ 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
*Correspondence to: H. L. Walter, Department of Neurology, University
Hospital Cologne, Kerpener Straße 62, 50937 Cologne,
Germany. Tel: +49-(0)221-47889144.
E-mail address: helene.walter@uk-koeln.de (H. L. Walter).
 Both authors contributed equally to this study.
Abbreviations: CNS, central nervous system; MRI, magnetic
resonance imaging; PET, positron emission tomography; pMCAO,
permanent middle cerebral artery occlusion; USPIO, ultra small
supraparamagnetic iron oxide particles; VOI, volumes of interest.
Neuroscience 292 (2015) 71–80
71
(BY PDF Extractor SDK TRIAL VERSION)
2004, 2007). However, these findings have been questioned
by studies using transient stroke models in highfield
MRI (Desestret et al., 2009; Farr et al., 2011;
Harms et al., 2013). In addition dysregulation of natural
neuroinflammatory responses by USPIOs has been discussed
(Siglienti et al., 2006; Hsiao et al., 2008). Recent
results furthermore suggest that iron deposition naturally
occurs after stroke (Danielisova et al., 2004; Li et al.,
2009; Hagemeier et al., 2012) and other diseases associated
with persistent microglia activation (Zivadinov et al.,
2011).
The present study was conducted to evaluate the
validity of combined imaging by USPIO-MRI and
[11C]PK11195-PET as a method to longitudinally and
intraindividually analyze stroke-induced inflammatory
processes in the living organism.
EXPERIMENTAL PROCEDURES
Experimental design
Thirteen male Wistar rats underwent permanent middle
cerebral artery occlusion (pMCAO) by the macrosphere
model, which closely resembles the dynamic patterns of
neuroinflammatory procedures in human stroke (Gerriets
et al., 2003; Walberer et al., 2010). At day 6 (d6), d27,
and d55, animals were subjected to both MRI (T2, T2⁄)
and PET, using the tracer [11C]PK11195 to investigate
neuroinflammatory processes. Directly afterward,
USPIOs (300lmol Fe/kg) were injected intravenously
(iv) followed by another MRI 24 h later, i.e., at d7, d28
and d56, to analyze USPIO-associated signal-changes.
After the first MRI at d6, three rats were excluded from
the study due to significantly smaller infarcts without cortical
involvement. From the remaining 10 animals five were
sacrificed at d28 and five at d56 for endpoint analyses by
immunohistochemistry (Fig. 1A). Animals were not perfused
and therefore provided fresh frozen tissue.
Another group of 13 male Wistar rats served as a
control for stroke-associated iron-deposition. They
underwent pMCAO but were not subjected to USPIOs.
At d3 (n= 2), d7 (n= 2), d14 (n= 3), d28 (n= 3) and
d56 (n= 3) immunohistochemical analyses were
performed.
Animals and surgery
Animal procedures were in accordance with the German
Laws for Animal Protection and approved by the local
animal care committee and governmental authorities.
Rats (320–365 g) were anesthetized with isoflurane and
nitrous oxide/oxygen (65%/35%) and additionally
received Carprofen (Rimadyl; 5 mg/kg/day s.c. for
3 days) for surgery. Body temperature and respiration
rate were monitored by combination of in-house
equipment and DASYLab 9.0 (DasyLab,
Moenchengladbach, Germany).
MRI and PET
T2- and T2⁄-weighted MRI was performed on a 4.7 T
BioSpec system (Bruker BioSpin, Ettlingen, Germany),
PET imaging on a microPET Focus 220 scanner
(Concorde Microsystems, Inc., Knoxville, TN, USA; 63
image planes; 1.5-mm full width at half maximum). The
radiolabelled tracer [11C]PK11195 was produced as
described elsewhere in more detail (Hamacher et al.,
1986; Shah et al., 1994; Schroeter et al., 2009). Binding
potential of [11C]PK11195 was calculated by the simplified
reference tissue model (SRTM) using the contralateral
hemisphere as reference region (Lammertsma and
Hume, 1996).
Image analysis and volume quantification
To differentiate between phagocytic activity and other
neuroinflammatory processes in the brain, we coregistered
PET- and MR-images using the software
VINCI (Cizek et al., 2004). Specific volumes of interest
(VOIs, mm3) were defined: VOI(USPIO), VOI(USP
IO + PK), VOI(PK) and VOI(CNS) (Fig. 1B–D, Table 1).
MR-images were normalized in gray-scale intensity.
Accumulation of iron induced focal hypointense T2⁄signal
changes. For precise identification of USPIOs, the T2⁄-image
acquired 24 h after was digitally subtracted from a
T2⁄-image acquired before USPIO administration in each
animal (Fig. 1B). Here hyperintense areas represented
specifically USPIO+ tissue, excluding any other sources
of iron deposition that had been present before this effective
USPIO administration including potential remnants of
former USPIO injections on d28 and d56. The corresponding
VOI(USPIO) was reconfirmed on the hypointense signal
of T2⁄-MRI after USPIO application (Fig. 1B, Table 1)
and denominated the area of phagocytic activity after
stroke. Threshold for [11C]PK11195 associated VOI-
definition was 50% binding capacity of the tracer. A VOI
was thus accounted positive if it appeared in green or hotter
color. Fusing VOI(USPIO) on the [11C]PK11195-signal
allowed to define colocalization of USPIOs and
[11C]PK11195 leading to VOI(USPIO + P K) (Fig. 1C,
Table 1). The volume [11C]PK11195 was also quantified
representing VOI(PK) (Fig. 1D, Table 1). The volume
resulting from subtraction of VOI(USPIO + PK) from
VOI(PK) was regarded as non-phagocytic neuroinflammation
, namely VOI(CNS) (Fig. 1D, Table 1).
Immunohistochemistry
Fresh frozen slices (10lm) were stained with
Hematoxylin and Eosin (H&E), Anti-Iba1 (dilution
1:1000, Wako, Neuss, Germany, cat-# 019-19741) and
ED1/CD68 (dilution 1:4000, AbD Serotec, Oxford, UK,
cat-# MCA341) both using the ABC-Kit (Vector
Laboratories, Burlingame, CA, USA). The Prussian blue
reaction enhanced by diaminobenzidine detected iron
(Schroeter et al., 2004). In each staining result, the hemisphere
contralateral to ischemia served as a negative
control.
Statistical analysis
For statistical analysis we used Excel (Microsoft Office
Excel 2003) and SPSS-Statistics (IBM SPSS-Statistics
22). VOIs were defined in mm3 providing parametric
data. Student’s t-test was performed in paired groups,
results were defined significant at p< 0.05, confidence
72 H. L. Walter et al./Neuroscience 292 (2015) 71–80
(8.0.0.2542.138799190 PDF Extractor SDK TRIAL VERSIOn)
interval 0.95. Error bars in the graphs represent standarderrors
of the mean.
RESULTS
Dynamics of post-stroke inflammation
During the observation period of 56 days, the
inflammatory signal by [11C]PK11195, decreased over
time and moved from regions directly adjacent to the
infarct toward the thalamus (d28), and further toward
midbrain and pons (d56) (Fig. 2A, B). In line with
previous results, post-stroke inflammation peaked at d7.
Immunohistochemistry
Focal signals for iron (Fe) were present in all USPIO+
areas corresponding to the infarct-margin and periinfarct
region (Fig. 2C). Iba1-stained tissue confirmed the
presence of microglia in areas positive for
[11C]PK11195, located at the periinfarct zone and sites
of secondary injury within the hippocampus and
thalamus. ED1/CD68+ phagocytes occurred at the
infarct margin matching VOI(USPIO) (Fig. 2C). Highpower
images of the areas corresponding to iron
accumulation revealed Prussian-blue+ phagocytes with
internalized iron particles and ED1+ macrophages.
Iba1+ microglia here showed ramified and stellate
phenotypes grouped around vacuolic structures
(Fig. 2C; arrows).
Fig. 1. Study design (A) and image analysis by VINCI-software (B). (A) Stroke was induced by pMCAO in 10 male Wistar rats. D6: MRI (T2, T2⁄)
and PET ([11C]PK11195) followed by USPIO-application. D7: MRI (T2, T2⁄) visualizing effective USPIOs. Analog procedures on d27/28 and d55/56.
Immunohistochemical endpoint analysis of 5 animals each on d28 and day 56. (B) Subtracting T2⁄-weighted MRIs collected after from those
collected before USPIO-application leads to hyperintense signal in USPIO+ tissue. VOIs (red) are inserted and verified on T2⁄-MRI after USPIO
application (VOI(USPIO)). (C) Colocalization of USPIO-VOIs on the [11C]PK11195-signal equaling VOI(USPIO + PK) (white). (D) [11C]PK11195-
signal equals VOI(PK) (gray). Subtraction of VOI(USPIO + PK) leads to VOI(CNS). (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
Table 1. Volumes of interest (VOI) used for image analysis
Volume of interest
(VOI)
Definition Interpretation
VOI(USPIO) T2⁄-signal changes Phagocytes
VOI(PK) Accumulation of
[11C]PK11195
Neuroinflammation
VOI(USPIO + PK) Colocalization of
USPIOs and
[11C]PK11195
Phagocytic activity
of VOI(PK)
VOI(CNS) VOI(PK) without
VOI(USPIO + PK)
Non-phagocytic
neuroinflammation
H. L. Walter et al./Neuroscience 292 (2015) 71–80 73
(EVAL PDF Extractor SDK 8.0.0.2542-1934910946)
Further evaluation of animals that had not received
USPIOs (d3, d7, d14, d28 and d56 after MCAO)
revealed intra- and perilesional deposition of iron from
d14 (Fig. 3). Comparison to animals subjected to
USPIOs (d28, d56) did not show any specific difference
(Fig. 3) underlining the importance of subtracting preand
post-USPIO images (e.g., as volumes/VOIs) in the
longitudinal approach of in vivo imaging.
Fig. 2. (A) Coronal T2⁄-weighted MRI and corresponding coronal (co), horizontal (ho) and sagittal (sa) display of [11C]PK11195-PET with coregistered
VOI(USPIOs) and VOI(USPIO + PK) at d7, d28 and d56. (B) Analog multimodal imaging at d7, d28 of an animal followed for 4 weeks.
(C) Immunohistochemistry for iron, ED1 and Iba1 corresponding to the animal’s coronal images on d28, shown in B, scale bars in low-power images
1.000lm, in high-power images 10lm.
74 H. L. Walter et al./Neuroscience 292 (2015) 71–80
(DEMO PDF Extractor SDK 8.0.0.2542-557955227)
Quantitative analysis of post-stroke inflammation
Differential analysis of MRI before and 24 h after USPIO
application allowed effective definition of USPIO-induced
iron deposition at specific time-points after stroke.
Combined analysis with PET using the tracer
[11C]PK11195 enabled us to discriminate between
phagocytic activity and other sources of inflammation on
d7, d28 and d56 (Figs. 1B–D, and 2).
Quantitative analysis of the volumes representing
phagocytic activity (VOI(USPIOs)) and other
neuroinflammation (VOI(CNS)) revealed a significant
minority of phagocytic responses at d7 (Fig. 4A, B).
However, non-phagocytic inflammatory processes
significantly decreased from d7 to d28 (Fig. 4A). So the
quantity of phagocytic activity tended to prevail over
other neuroinflammation from d28 (Fig. 4B).
Morphological changes following neuroinflammation
Comparing MRI/PET results from day 7 with
corresponding H&E-stained brain slices at the endpoint
d28 or d56 enabled us to study the morphological fate
of each VOI. Morphology was characterized by H&E-
staining as cavity, infarct margin, or viable tissue. The
corresponding tissue was then attributed to predefined
VOIs in PET- and MR-images (USPIO, PK,
USPIO + PK) (Fig. 5). On d7 USPIOs occurred within
the finally necrotic cavity of the infarct in 100% and
within the lesioned infarct-margin in at least 75% of the
animals. Accordingly [11C]PK11195-accumulation was
present in viable tissue or infarct margin. Colocation of
USPIO and [11C]PK11195 was mainly observed in
tissue belonging to infarct margin. As a result cerebral
tissue invaded by USPIO-loaded phagocytes
(VOI(USPIO)) on d7 mostly succumbed to necrotic
infarct cavity or to highly injured infarct margin. Regions
lacking USPIOs but presenting only [11C]PK11195-
accumulation (VOI(CNS)) thus mainly remained viable
and were located in the peri-infarct region or sites of
secondary tissue modulation.
All five 56d-animals received PET-imaging on d7. One
d7-imaging session of a 28d-animal failed due to technical
reasons, so there were only four 28d-animals available in
this set.
DISCUSSION
To date, the detailed pathomechanisms underlying
stroke-induced inflammatory processes still remain
elusive and especially the distinction of various cellular
subtypes contributing to postischemic reactions is
matter of vivid debates (Prinz et al., 2011). Cellular and
genetic labeling as well as functional studies have shown
that in particular the microglia/macrophage population is
highly heterogeneous in respect to origin, activity and
marker expression (Morrison and Filosa, 2013; Perego
et al., 2013). This study in vivo investigates the phagocytic
activity of neuroinflammation in the late chronic phase
after experimental stroke by multimodal imaging using
USPIO-MRI and [11C]PK11195-PET in longitudinal
fashion.
USPIOs as a tool to visualize phagocytic activity after
stroke
It has repeatedly been demonstrated that USPIO particles
might induce false-positive effects due to intravascular
trapping, blood pool effects or passive diffusion through
a defective blood–brain barrier (Deddens et al., 2012;
Harms et al., 2013). These factors could, at least in
principle, have caused an overestimation of phagocytic
activity in the present study, especially concerning
USPIO-signals located within the necrotic infarct core
and close to meningeal surfaces (Farr et al., 2011).
However, observations described in the literature primarily
occurred early, such as the first 24 h or maximum 6d after
stroke-onset. According to our literature research, this
study is the first concentrating on later phases (d7–d56)
after stroke implying different inflammatory processes.
Although blood half-life of USPIOs generally does not
extend 6 h (Deddens et al., 2012) additive signals by remnants
of USPIOs could be discussed, especially in data
from d28 and d56. Our experimental setup with in vivo
digital subtraction of T2⁄-images acquired 24 h before
USPIO administration in each animal at each time-point
excluded any signal not related to the latest USPIO
injection. This is in contrast to our immunohistochemical
approaches, which did not succeed to distinguish
between the different origins of iron deposition, that also
physiologically occur in the brain (Wegst-Uhrich et al.,
2014). Immunohistochemistry in perfused tissue could
minimize blood smears and microbleeds as sources of
error but would not allow any further discrimination of iron
either. Targeted USPIOs could solve the problem of
ex vivo identification in future (Gauberti et al., 2014).
We hypothesize that effects of additional iron possibly
deposited within 24 h between MRI-scans are negligible.
Our observations are rather limited by the fact, that T2⁄-
signaling naturally expands the real size of iron
particles, potentially leading to an overestimation of
USPIO quantities. Thus a wider expansion and even
longer duration of non-phagocytic inflammatory
procedures in the brain should be discussed. In our
study, data suggest only a slight preponderance of
phagocytic activity especially on d28, when other CNS-
inflammation might still have prominent value (Fig. 4).
Prediction of individual tissue-outcome
We show that after stroke sites of non-phagocytic
inflammatory processes at d7 tend to remain viable
tissue at d28 and d56 (Fig. 5). Although lacking any
statistical significance, this finding supports the
hypothesis that ramified and stellate phenotypes of
microglia are not only involved in degeneration but also,
and maybe even primarily, in controlled remodeling of
tissue after cerebral ischemia (Wake et al., 2009;
Kettenmann et al., 2013). This notion is corroborated by
our finding, that not phagocytes but other processes of
neuroinflammation evolved via the thalamus toward the
midbrain, possibly following or maybe even foregoing
Wallerian degeneration (Radlinska et al., 2009; Thiel
et al., 2010).
H. L. Walter et al./Neuroscience 292 (2015) 71–80 75
(PDF Extractor SDK TRIAL VERSION)
Fig. 3. Iron-stained naı¨ve brains (no USPIOs) reveal perilesional iron-deposition from d14 (arrows). Comparison to USPIO-subjected brains
(+USPIO) remains unspecific.
Fig. 4. Quantitative analysis of inflammation (mm3) at d7, d28 and d56: non-phagocytic neuroinflammation (CNS, VOI(CNS)) and phagocytic
activity (USPIO, VOI(USPIO)). (A) Comparison of VOI(CNS) and VOI(USPIO). Significant dominance of VOI(CNS) at d7, significant decrease of
VOI(CNS) at d28. (B) Relation of VOI(CNS) to VOI(USPIO).
76 H. L. Walter et al./Neuroscience 292 (2015) 71–80
(PDF Extractor SDK TRIAL VERSION)
To our knowledge, this study is the first indicating
in vivo that viable tissue where USPIOs accumulate at
d7 succumbs to necrosis until d56 (Fig. 5). This may
suggest destructive functions of phagocytic activity in
the postischemic brain, which has been discussed in
in vitro-studies before (Schilling et al., 2009; Evans
et al., 2014). However, this effect may be misjudged.
USPIO+ cells primarily invaded primarily lesioned tissue,
located within the infarct core or margin, presumably
already on a ‘‘way of no return’’ toward necrosis.
Secondary cleansing and removal of these areas probably
most effectively contributes to healing processes.
Fig. 5. Necrotic cavitiy (red), essentially lesioned infarct-margin (orange) and still viable periinfarct tissue (yellow) were classified by H&E-stained
brain-slices on d28 and d56 (n(d28) = 4, n(d56) = 5). USPIO- and [11C]PK11195-accumulation from d7 lead to different histological fates:
VOI(USPIO) d7: 100% of the animals presented USPIO-accumulation in the necrotic cavity at each timepoint. USPIOs occurred within the lesioned
infarct-margin 75% of the animals on d28 and100% of the animals on d56. VOI(PK) d7: 100% of the animals presented [11C]PK11195-accumulation
in viable tissue or lesioned infarct margin on d28 and d56. VOI(USPIO + PK) d7: on d28 100% of the animals presented USPIO/[11C]PK11195-
colocation within the lesioned infarct margin, 80% on d56. (For interpretation of the references to color in this figure legend, the reader is referredto
the web version of this article.)
H. L. Walter et al./Neuroscience 292 (2015) 71–80 77
(EVALUATION PDF Extractor SDK 8.0.0.2542.1747639192)
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0005
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0005
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0005
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0005
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0010
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0010
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0010
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0015
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0015
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0015
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0020
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0020
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0020
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0020
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0025
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0025
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0030
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0030
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0030
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0030
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0030
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0035
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0035
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0035
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0035
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0035
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0040
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0045
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0045
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0045
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0045
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0045
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0050
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0050
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0050
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0050
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0055
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0055
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0055
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0060
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0060
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0060
Consequently down-regulation of phagocytic responses
to stroke will not necessarily lead to a better outcome
(Schilling et al., 2009).
Differentiation of postischemic inflammatory
processes in vivo
Discrimination of microglia from other inflammatory cells
invading the site of ischemic injury by immunohistochemical
markers remains unreliable. Alternative
and more valid methods are bone-marrow labeling of
cells in chimeric organisms (Tanaka et al., 2003) or creation
of specific genetically modified variants (Jung
et al., 2000; Lalancette-Hebert et al., 2009). Bone-marrow-chimera
elegantly demonstrated that brain resident
precedes blood-derived inflammatory responses after
stroke (Tanaka et al., 2003; Schilling et al., 2005) reproducing
earlier results of depletion experiments
(Schroeter et al., 1997). In vivo cellular imaging in
genetically modified organisms by 2-photon-laser-microscopy
confirmed these findings by showing a rapid
response to tissue alterations in the brain by microglia
but not blood-derived macrophages (Nimmerjahn et al.,
2005; Wake et al., 2009).
In our study we detected macrophages by
intravenously applied USPIOs in T2⁄-weighted MRI at 7,
28 and 56 days after stroke (Fig. 1). After invading the
CNS, however, hematogenously derived USPIO+ cells
can be taken up by locally activated microglia, impeding
the discrimination of blood-derived and brain-resident
phagocytes (Fleige et al., 2001; Wiart et al., 2007). Our
data, however, demonstrate focal signals of USPIOs in
the infarct’s cavity and at its boarder zone, but unlike
microglia not at sites of secondary tissue modulation as
the thalamus or the hippocampus. Furthermore we found
non-phagocytosing phenotypes of microglia within
USPIO+ areas, indicating that, at least in our setup, the
amount of secondarily internalized USPIOs is probably
low (Fig. 2C). Moreover the dynamics of USPIO-signals
presented in this study are notably typical for bloodderived
inflammatory processes as evidenced by bone
marrow chimera experiments, the gold standard in discriminating
blood derived from brain-resident inflammation
(Schilling et al., 2005). We therefore suggest, that
the co-registration of USPIO-MRI and [11C]PK11195-
PET might be able to approximately differentiate
brain-resident and hematogenous fractions of neuroinflammation
(Figs. 2, 4). In contrast to methods using
bone-marrow-chimera or transgenic organisms, USPIOMRI
and [11C]PK11195-PET are applicable for wildtype,
immunologically unaffected organism, ensuring longitudinal
and intraindividual monitoring of natural inflammatory
responses (Kierdorf and Prinz, 2013).
CONCLUSION
The combination of USPIO-MRI and [11C]PK11195-PET
allows longitudinal and intra-individual analysis of
inflammatory processes in the chronic post-stroke
phase, facilitating valid predictions about regional tissue
fate. Hereby valuable information about mechanisms of
repair and recovery after stroke is provided. As both
methods have successfully been applied in humans,
translation of this multi-modal imaging protocol into
clinical routine is feasible and may help to monitor new
therapeutic approaches.
SOURCES OF FUNDING
This study was supported by the Ko ¨ ln-Fortune-
Programme and the European Community’s Seventh
Framework Programme, project number 2780006,
‘‘NeuroFGL’’.
DISCLOSURES
The authors declare no competing financial interests.
Acknowledgment—None.
REFERENCES
Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO):
molecular sensor of brain injury and repair. Pharmacol Ther
118:1–17.
Cizek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD (2004)
Fast and robust registration of PET and MR images of human
brain. Neuroimage 22:434–442.
Danielisova V, Nemethova M, Burda J (2004) Iron deposition in the
brain following the ischemia in a rat model of ischemic tolerance.
Acta Medica (Hradec Kralove) 47:285–288.
Deddens LH, Van Tilborg GA, Mulder WJ, De Vries HE, Dijkhuizen
RM (2012) Imaging neuroinflammation after stroke: current status
of cellular and molecular MRI strategies. Cerebrovasc Dis
33:392–402.
del Zoppo GJ (2010) Acute anti-inflammatory approaches to ischemic
stroke. Ann N Y Acad Sci 1207:143–148.
Desestret V, Brisset JC, Moucharrafie S, Devillard E, Nataf S,
Honnorat J, Nighoghossian N, Berthezene Y, Wiart M (2009)
Early-stage investigations of ultrasmall superparamagnetic iron
oxide-induced signal change after permanent middle cerebral
artery occlusion in mice. Stroke 40:1834–1841.
Desestret V, Riou A, Chauveau F, Cho TH, Devillard E, Marinescu M,
Ferrera R, Rey C, Chanal M, Angoulvant D, Honnorat J,
Nighoghossian N, Berthezene Y, Nataf S, Wiart M (2013) In
vitro and in vivo models of cerebral ischemia show discrepancy in
therapeutic effects of M2 macrophages. PLoS One 8:e67063.
Dickens AM, Vainio S, Marjamaki P, Johansson J, Lehtiniemi P,
Rokka J, Rinne J, Solin O, Haaparanta-Solin M, Jones PA, Trigg
W, Anthony DC, Airas L (2014) Detection of microglial activation
in an acute model of neuroinflammation using PET and
radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med
55:466–472.
Evans TA, Barkauskas DS, Myers JT, Hare EG, You JQ, Ransohoff
RM, Huang AY, Silver J (2014) High-resolution intravital imaging
reveals that blood-derived macrophages but not resident
microglia facilitate secondary axonal dieback in traumatic spinal
cord injury. Exp Neurol 254C:109–120.
Farr TD, Seehafer JU, Nelles M, Hoehn M (2011) Challenges towards
MR imaging of the peripheral inflammatory response in the
subacute and chronic stages of transient focal ischemia. NMR
Biomed 24:35–45.
Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer
C (2001) Magnetic labeling of activated microglia in experimental
gliomas. Neoplasia 3:489–499.
Fumagalli S, Perego C, Ortolano F, De Simoni MG (2013) CX3CR1
deficiency induces an early protective inflammatory environment
in ischemic mice. Glia 61:827–842.
78 H. L. Walter et al./Neuroscience 292 (2015) 71–80
(BY PDF Extractor SDK TRIAL VERSION)
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0065
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0065
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0065
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0070
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0070
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0070
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0070
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0075
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0075
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0075
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0080
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0085
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0090
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0090
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0090
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0095
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0095
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0095
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0095
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0100
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0100
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0100
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0105
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0110
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0110
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0110
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0110
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0115
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0115
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0120
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0120
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0125
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0125
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0125
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0125
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0130
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0130
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0135
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0135
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0135
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0135
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0140
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0140
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0140
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0140
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0145
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0145
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0145
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0150
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0150
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0155
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0155
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0155
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0155
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0155
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0160
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0160
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0160
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0165
[Link]
http://dx.doi.org/10.3791/50605
[Link]
http://dx.doi.org/10.3791/50605
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0175
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0175
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0175
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0180
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0180
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0180
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0180
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0185
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0185
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0185
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0190
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0190
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0190
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0190
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0195
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0195
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0195
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0195
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0200
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0200
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0200
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0200
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0205
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0210
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0210
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0210
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0210
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0215
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0215
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0215
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0215
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0220
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0220
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0220
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0220
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0225
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0230
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0230
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0230
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0230
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0230
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0235
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0235
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0235
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0240
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0240
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0240
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0240
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0245
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0245
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0245
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0250
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0250
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0250
Gauberti M, Montagne A, Quenault A, Vivien D (2014) Molecular
magnetic resonance imaging of brain–immune interactions. Front
Cell Neurosci 8:389.
Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, Fisher M
(2003) The macrosphere model: evaluation of a new stroke model
for permanent middle cerebral artery occlusion in rats. J Neurosci
Methods 122:201–211.
Hagemeier J, Geurts JJ, Zivadinov R (2012) Brain iron accumulation
in aging and neurodegenerative disorders. Expert Rev Neurother
12:1467–1480.
Hamacher K, Coenen HH, Stocklin G (1986) Efficient stereospecific
synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose
using aminopolyether supported nucleophilic substitution. J Nucl
Med 27:235–238.
Harms C, Datwyler AL, Wiekhorst F, Trahms L, Lindquist R,
Schellenberger E, Mueller S, Schutz G, Roohi F, Ide A,
Fuchtemeier M, Gertz K, Kronenberg G, Harms U, Endres M,
Dirnagl U, Farr TD (2013) Certain types of iron oxide
nanoparticles are not suited to passively target inflammatory
cells that infiltrate the brain in response to stroke. J Cereb Blood
Flow Metab 33:e1–e9.
Heiss WD (2014) PET imaging in ischemic cerebrovascular
disease: current status and future directions. Neurosci Bull 30:
713–732.
Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL,
Liu HM (2008) Macrophage physiological function after
superparamagnetic iron oxide labeling. NMR Biomed
21:820–829.
Jacobs AH, Tavitian B, Consortium IN (2012) Noninvasive molecular
imaging of neuroinflammation. J Cereb Blood Flow Metab
32:1393–1415.
Jucaite A, Cselenyi Z, Arvidsson A, Ahlberg G, Julin P, Varnas K,
Stenkrona P, Andersson J, Halldin C, Farde L (2012) Kinetic
analysis and test-retest variability of the radioligand [11C](R)-
PK11195 binding to TSPO in the human brain – a PET study in
control subjects. EJNMMI Res 2:15.
Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher
A, Littman DR (2000) Analysis of fractalkine receptor CX(3)CR1
function by targeted deletion and green fluorescent protein
reporter gene insertion. Mol Cell Biol 20:4106–4114.
Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles
for the synaptic stripper. Neuron 77:10–18.
Kierdorf K, Prinz M (2013) Factors regulating microglia activation.
Front Cell Neurosci 7:44.
Lalancette-Hebert M, Phaneuf D, Soucy G, Weng YC, Kriz J (2009)
Live imaging of Toll-like receptor 2 response in cerebral
ischaemia reveals a role of olfactory bulb microglia as
modulators of inflammation. Brain 132:940–954.
Lammertsma AA, Hume SP (1996) Simplified reference tissue model
for PET receptor studies. Neuroimage 4:153–158.
Li L, Li YW, Zhao JY, Liu YZ, Holscher C (2009) Quantitative analysis
of iron concentration and expression of ferroportin 1 in the cortex
and hippocampus of rats induced by cerebral ischemia. J Clin
Neurosci 16:1466–1472.
Marinescu M, Chauveau F, Durand A, Riou A, Cho TH, Dencausse A,
Ballet S, Nighoghossian N, Berthezene Y, Wiart M (2013)
Monitoring therapeutic effects in experimental stroke by serial
USPIO-enhanced MRI. Eur Radiol 23:37–47.
Morrison HW, Filosa JA (2013) A quantitative spatiotemporal analysis
of microglia morphology during ischemic stroke and reperfusion. J
Neuroinflammation 10:4.
Murphy TH, Corbett D (2009) Plasticity during stroke recovery: from
synapse to behaviour. Nat Rev Neurosci 10:861–872.
Nighoghossian N, Wiart M, Cakmak S, Berthezene Y, Derex L, Cho
TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P,
Froment JC, Hermier M (2007) Inflammatory response after
ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke
38:303–307.
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial
cells are highly dynamic surveillants of brain parenchyma in vivo.
Science 308:1314–1318.
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ,
Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR,
Gavish M (2006) Translocator protein (18 kDa): new
nomenclature for the peripheral-type benzodiazepine receptor
based on its structure and molecular function. Trends Pharmacol
Sci 27:402–409.
Perego C, Fumagalli S, De Simoni MG (2013) Three-dimensional
confocal analysis of microglia/macrophage markers of
polarization in experimental brain injury. J Vis Exp (79). http://
dx.doi.org/10.3791/50605.
Prinz M, Priller J, Sisodia SS, Ransohoff RM (2011) Heterogeneity of
CNS myeloid cells and their roles in neurodegeneration. Nat
Neurosci 14:1227–1235.
Quattromani MJ, Cordeau P, Ruscher K, Kriz J, Wieloch T (2014)
Enriched housing down-regulates the Toll-like receptor 2
response in the mouse brain after experimental stroke.
Neurobiol Dis 66:66–73.
Radlinska BA, Ghinani SA, Lyon P, Jolly D, Soucy JP, Minuk J,
Schirrmacher R, Thiel A (2009) Multimodal microglia imaging of
fiber tracts in acute subcortical stroke. Ann Neurol 66:825–832.
Ruscher K, Kuric E, Liu Y, Walter HL, Issazadeh-Navikas S, Englund
E, Wieloch T (2013) Inhibition of CXCL12 signaling attenuates the
postischemic immune response and improves functional recovery
after stroke. J Cereb Blood Flow Metab 33:1225–1234.
Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S,
Hoehn M (2004) Central nervous system inflammatory response
after cerebral infarction as detected by magnetic resonance
imaging. NMR Biomed 17:163–169.
Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Modder
U, Jander S (2007) Iron oxide particle-enhanced MRI suggests
variability of brain inflammation at early stages after ischemic
stroke. Stroke 38:2733–2737.
Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB,
Kiefer R (2005) Predominant phagocytic activity of resident
microglia over hematogenous macrophages following transient
focal cerebral ischemia: an investigation using green fluorescent
protein transgenic bone marrow chimeric mice. Exp Neurol
196:290–297.
Schilling M, Strecker JK, Schabitz WR, Ringelstein EB, Kiefer R
(2009) Effects of monocyte chemoattractant protein 1 on bloodborne
cell recruitment after transient focal cerebral ischemia in
mice. Neuroscience 161:806–812.
Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G (1997)
Phagocytic response in photochemically induced infarction of rat
cerebral cortex. The role of resident microglia. Stroke
28:382–386.
Schroeter M, Saleh A, Wiedermann D, Hoehn M, Jander S (2004)
Histochemical detection of ultrasmall superparamagnetic iron
oxide (USPIO) contrast medium uptake in experimental brain
ischemia. Magn Reson Med 52:403–406.
Schroeter M, Dennin MA, Walberer M, Backes H, Neumaier B, Fink
GR, Graf R (2009) Neuroinflammation extends brain tissue at risk
to vital peri-infarct tissue: a double tracer [11C]PK11195- and
[18F]FDG-PET study. J Cereb Blood Flow Metab 29:1216–1225.
Shah F, Hume SP, Pike VW, Ashworth S, McDermott J (1994)
Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and
comparison of their behaviours as radioligands for PK binding
sites in rats. Nucl Med Biol 21:573–581.
Siglienti I, Bendszus M, Kleinschnitz C, Stoll G (2006) Cytokine
profile of iron-laden macrophages: implications for cellular
magnetic resonance imaging. J Neuroimmunol 173:166–173.
Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR,
Clemens JA (1995) Peripheral benzodiazepine receptors are
colocalized with activated microglia following transient global
forebrain ischemia in the rat. J Neurosci 15:5263–5274.
Stoll G, Bendszus M (2010) New approaches to neuroimaging of
central nervous system inflammation. Curr Opin Neurol
23:282–286.
Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T,
Migita M, Shimada T, Mizuno Y, Urabe T (2003) Migration of
enhanced green fluorescent protein expressing bone marrow-
H. L. Walter et al./Neuroscience 292 (2015) 71–80 79
(DEMO PDF Extractor SDK 8.0.0.2542-438467619)
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0250
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0250
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0255
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0260
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0260
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0260
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0260
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0265
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0265
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0265
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0265
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0265
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0270
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0270
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0270
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0270
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0270
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0275
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0275
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0275
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0275
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0280
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0280
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0285
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0285
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0285
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0285
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0290
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0290
[Link]
http://refhub.elsevier.com/S0306-4522(15)00176-1/h0290
derived microglia/macrophage into the mouse brain following
permanent focal ischemia. Neuroscience 117:531–539.
Thiel A, Radlinska BA, Paquette C, Sidel M, Soucy JP, Schirrmacher
R, Minuk J (2010) The temporal dynamics of poststroke
neuroinflammation: a longitudinal diffusion tensor imagingguided
PET study with 11C-PK11195 in acute subcortical stroke.
J Nucl Med 51:1404–1412.
Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009)
Resting microglia directly monitor the functional state of synapses
in vivo and determine the fate of ischemic terminals. J Neurosci
29:3974–3980.
Walberer M, Dennin MA, Simard ML, Emig B, Jander S, Fink GR,
Schroeter M (2010) Dynamics of neuroinflammation in the
macrosphere model of arterio-arterial embolic focal ischemia: an
approximation to human stroke patterns. Exp Transl Stroke Med
2:22.
Wegst-Uhrich SR, Mullin EJ, Ding D, Manohar S, Salvi R, Aga DS,
Roth JA (2014) Endogenous concentrations of biologically
relevant metals in rat brain and cochlea determined by
inductively coupled plasma mass spectrometry. Biometals
28:187–196.
Wiart M, Davoust N, Pialat JB, Desestret V, Moucharrafie S, Cho TH,
Mutin M, Langlois JB, Beuf O, Honnorat J, Nighoghossian N,
Berthezene Y (2007) MRI monitoring of neuroinflammation in
mouse focal ischemia. Stroke 38:131–137.
Wieloch T, Nikolich K (2006) Mechanisms of neural plasticity
following brain injury. Curr Opin Neurobiol 16:258–264.
Yang YM, Feng X, Yin LK, Li CC, Jia J, Du ZG (2013) Comparison of
USPIO-enhanced MRI and Gd-DTPA enhancement during the
subacute stage of focal cerebral ischemia in rats. Acta Radiol
55:864–873.
Zivadinov R, Weinstock-Guttman B, Pirko I (2011) Iron deposition
and inflammation in multiple sclerosis. Which one comes first?
BMC Neurosci 12:60.
(Accepted 11 February 2015)
(Available online 18 February 2015)
80 H. L. Walter et al./Neuroscience 292 (2015) 71–80
(DEMO PDF Extractor SDK 8.0.0.2542-438467619)
